These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19630745)

  • 1. Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.
    Norman LR; Basso M; Kumar A; Malow R
    Curr Drug Abuse Rev; 2009 May; 2(2):143-56. PubMed ID: 19630745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.
    Norman LR; Basso M
    Curr Drug Abuse Rev; 2015; 8(1):50-71. PubMed ID: 25751583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.
    Hinkin CH; Hardy DJ; Mason KI; Castellon SA; Durvasula RS; Lam MN; Stefaniak M
    AIDS; 2004 Jan; 18 Suppl 1(Suppl 1):S19-25. PubMed ID: 15075494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Important Role of Mental Illness and Substance Abuse in Successful Management of HIV Infection.
    Brion J; Kemppainen J
    J Assoc Nurses AIDS Care; 2017; 28(2):181-184. PubMed ID: 28236902
    [No Abstract]   [Full Text] [Related]  

  • 5. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.
    Mellins CA; Havens JF; McDonnell C; Lichtenstein C; Uldall K; Chesney M; Santamaria EK; Bell J
    AIDS Care; 2009 Feb; 21(2):168-77. PubMed ID: 19229685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
    Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
    Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric aspects of HIV infection among older adults.
    Hinkin CH; Castellon SA; Atkinson JH; Goodkin K
    J Clin Epidemiol; 2001 Dec; 54 Suppl 1(Suppl 1):S44-52. PubMed ID: 11750209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.
    Lucas GM
    Life Sci; 2011 May; 88(21-22):948-52. PubMed ID: 20888839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing HIV treatment adherence among multidiagnosed clients.
    Laird S; Krouss E
    Focus; 2002 Aug; 17(9):1-5. PubMed ID: 12243131
    [No Abstract]   [Full Text] [Related]  

  • 10. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV/AIDS and homelessness, Part 2: treatment issues.
    Douaihy AB; Stowell KR; Bui T; Daley D; Salloum I
    AIDS Read; 2005 Nov; 15(11):604-6, 611-3, 618. PubMed ID: 16329182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV & psychiatric disorders.
    Chandra PS; Desai G; Ranjan S
    Indian J Med Res; 2005 Apr; 121(4):451-67. PubMed ID: 15817956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of a cognitive ability battery among HIV+ intravenous drug users evaluated in a study of medication adherence.
    Ownby RL; Kumar M; Waldrop-Valverde D
    Int J Neurosci; 2005 Sep; 115(9):1259-71. PubMed ID: 16048805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive function in HIV-1-infected drug users.
    Shor-Posner G
    J Acquir Immune Defic Syndr; 2000 Oct; 25 Suppl 1():S70-3. PubMed ID: 11126430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: a review of the literature.
    Uldall KK; Palmer NB; Whetten K; Mellins C;
    AIDS Care; 2004; 16 Suppl 1():S71-96. PubMed ID: 15736823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive impairment and HIV risk factors: a reciprocal relationship.
    Anand P; Springer SA; Copenhaver MM; Altice FL
    AIDS Behav; 2010 Dec; 14(6):1213-26. PubMed ID: 20232242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric complications of aging with HIV.
    Watkins CC; Treisman GJ
    J Neurovirol; 2012 Aug; 18(4):277-90. PubMed ID: 22644745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance abuse treatment in persons with HIV/AIDS: challenges in managing triple diagnosis.
    Durvasula R; Miller TR
    Behav Med; 2014; 40(2):43-52. PubMed ID: 24274175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS.
    Weiser SD; Young SL; Cohen CR; Kushel MB; Tsai AC; Tien PC; Hatcher AM; Frongillo EA; Bangsberg DR
    Am J Clin Nutr; 2011 Dec; 94(6):1729S-1739S. PubMed ID: 22089434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.